VLPCOV-U-01

N/A

Report date: 2026/03/26 20:00:17

Base Information

Drug NameVLPCOV-U-01

Drug Alias NameSARS-CoV-2 Vaccine VLPCOV-U-01(VLP Therapeutics)VLPCOV-U-01

ClassificationVaccines > Development/production technology > Nucleic acid vaccine > RNA vaccine > self-amplifying RNA vaccineVaccines > Application > Prophylactic vaccine

Mechanisms of ActionImmunostimulants

TargetsNot applicable

Therapy Area/IndicationsCoronavirus Disease 2019 (COVID-19)

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryJapan

CombinationsNo

Global Highest StatusPhase 1 Clinical

Highest Status in ChinaN/A

Originator CompaniesVLP Therapeutics Inc

China Registration ClassN/A

Develop Information

Active CompaniesVLP Therapeutics Inc

Inactive CompaniesN/A

Active IndicationsCoronavirus Disease 2019 (COVID-19)

Inactive IndicationsN/A

Other Information

ATC CodeN/A